Omega Healthcare Investors Stock Performance
OHI Stock | USD 37.12 1.22 3.40% |
The company holds a Beta of -0.31, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Omega Healthcare are expected to decrease at a much lower rate. During the bear market, Omega Healthcare is likely to outperform the market. At this point, Omega Healthcare Inv has a negative expected return of -0.11%. Please make sure to check Omega Healthcare's skewness, and the relationship between the treynor ratio and rate of daily change , to decide if Omega Healthcare Inv performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Omega Healthcare Investors has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's technical indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more
Actual Historical Performance (%)
One Day Return (1.35) | Five Day Return 1.52 | Year To Date Return (3.30) | Ten Year Return (8.59) | All Time Return 85.14 |
Forward Dividend Yield 0.0722 | Payout Ratio | Forward Dividend Rate 2.68 | Dividend Date 2025-02-18 | Ex Dividend Date 2025-02-10 |
1 | Acquisition by Barbara Hill of 7472 shares of Omega Healthcare subject to Rule 16b-3 | 12/13/2024 |
2 | Disposition of tradable shares by Neal Ballew of Omega Healthcare at 37.85 subject to Rule 16b-3 | 12/31/2024 |
3 | Alleviant Medical raises 90M for no-implant atrial shunt | 01/14/2025 |
4 | Ellie Mental Health Announces CEO Succession Plan Founder Erin Pash Becomes Chairwoman of the Board | 01/29/2025 |
5 | Acquisition by Neal Ballew of 12960 shares of Omega Healthcare subject to Rule 16b-3 | 01/31/2025 |
6 | Omega Healthcare Investors Issues FY 2025 Earnings Guidance | 02/06/2025 |
7 | Omega Systems Named to CRNs 2025 MSP 500 List in the Elite 150 Category | 02/10/2025 |
8 | Omega Healthcare Debuts with a 96.7 Overall Performance Score in the Best in KLAS 2025 Ambulatory RCM Services Category | 02/11/2025 |
9 | Can math save content creators A new model proposes fairer revenue distribution methods for streaming services | 02/12/2025 |
10 | Inspr Embassy Row Celebrates Grand Opening, Ushering in New Era of Luxury Senior Living in Washington D.C. | 02/13/2025 |
11 | Omega Healthcare Investors, Inc. Shares Sold by Bright Futures Wealth Management LLC. | 02/14/2025 |
Omega Healthcare dividend paid on 18th of February 2025 | 02/18/2025 |
12 | Chronic Inflammation Our Nutritional Expert Shares Causes, Best Worst Foods To Manage Inflammation | 02/19/2025 |
Begin Period Cash Flow | 444.7 M | |
Free Cash Flow | 749.4 M |
Omega |
Omega Healthcare Relative Risk vs. Return Landscape
If you would invest 3,989 in Omega Healthcare Investors on November 29, 2024 and sell it today you would lose (277.00) from holding Omega Healthcare Investors or give up 6.94% of portfolio value over 90 days. Omega Healthcare Investors is generating negative expected returns assuming volatility of 1.4253% on return distribution over 90 days investment horizon. In other words, 12% of stocks are less volatile than Omega, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
Risk |
Omega Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Omega Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Omega Healthcare Investors, and traders can use it to determine the average amount a Omega Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0785
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | OHI |
Estimated Market Risk
1.43 actual daily | 12 88% of assets are more volatile |
Expected Return
-0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Omega Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Omega Healthcare by adding Omega Healthcare to a well-diversified portfolio.
Omega Healthcare Fundamentals Growth
Omega Stock prices reflect investors' perceptions of the future prospects and financial health of Omega Healthcare, and Omega Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Omega Stock performance.
Return On Equity | 0.0984 | ||||
Return On Asset | 0.0434 | ||||
Profit Margin | 0.39 % | ||||
Operating Margin | 0.63 % | ||||
Current Valuation | 14.64 B | ||||
Shares Outstanding | 281.84 M | ||||
Price To Earning | 30.17 X | ||||
Price To Book | 2.27 X | ||||
Price To Sales | 10.21 X | ||||
Revenue | 1.05 B | ||||
Gross Profit | 1.05 B | ||||
EBITDA | 947.11 M | ||||
Net Income | 417.8 M | ||||
Cash And Equivalents | 297.1 M | ||||
Cash Per Share | 0.70 X | ||||
Total Debt | 4.84 B | ||||
Debt To Equity | 1.35 % | ||||
Current Ratio | 2.57 X | ||||
Book Value Per Share | 16.25 X | ||||
Cash Flow From Operations | 749.43 M | ||||
Earnings Per Share | 1.53 X | ||||
Market Capitalization | 10.74 B | ||||
Total Asset | 9.9 B | ||||
Retained Earnings | (3.43 B) | ||||
Working Capital | 2.31 B | ||||
Current Asset | 223.89 M | ||||
Current Liabilities | 15.35 M | ||||
About Omega Healthcare Performance
By evaluating Omega Healthcare's fundamental ratios, stakeholders can gain valuable insights into Omega Healthcare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Omega Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Omega Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 9.7 K | 10.2 K | |
Return On Tangible Assets | 0.04 | 0.03 | |
Return On Capital Employed | 0.10 | 0.08 | |
Return On Assets | 0.04 | 0.03 | |
Return On Equity | 0.09 | 0.06 |
Things to note about Omega Healthcare Inv performance evaluation
Checking the ongoing alerts about Omega Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Omega Healthcare Inv help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Omega Healthcare Inv generated a negative expected return over the last 90 days | |
Over 77.0% of the company shares are owned by institutional investors | |
On 18th of February 2025 Omega Healthcare paid $ 0.67 per share dividend to its current shareholders | |
Latest headline from ndtv.com: Chronic Inflammation Our Nutritional Expert Shares Causes, Best Worst Foods To Manage Inflammation |
- Analyzing Omega Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Omega Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Omega Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Omega Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Omega Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Omega Healthcare's stock. These opinions can provide insight into Omega Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Omega Stock analysis
When running Omega Healthcare's price analysis, check to measure Omega Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Healthcare is operating at the current time. Most of Omega Healthcare's value examination focuses on studying past and present price action to predict the probability of Omega Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omega Healthcare's price. Additionally, you may evaluate how the addition of Omega Healthcare to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
CEOs Directory Screen CEOs from public companies around the world |